HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Efforts intensify to ensure accessibility, sustainability of HSCT
-
- Novel treatment strategy needed for patients at high risk for metastatic disease recurrence David H. Ilson, MD, PhD
- ASCO updates survivorship care template to improve frequency, ease of use
- Hematology Drugs in the Pipeline
- Data-based medicine: When data and ‘opinion’ collide John Sweetenham, MD, FRCP, FACP
- Akynzeo approved for CINV
- FDA approves Obizur for acquired hemophilia A
- FDA grants fast track designation to TAS-102 for mCRC
- PIK3CA mutation associated with poorer response in HER-2–positive breast cancer
-
- Two novel mutations linked to ALK inhibitor resistance in NSCLC
- Anti-CD19 CAR T cells show promise in chemotherapy-refractory DLBCL
- Increased prostate, pancreatic cancer risks among BRCA mutation carriers support additional screening
- Lung cancer diagnostic test loses specificity in areas with endemic lung infections
- Nivolumab induced durable remissions in advanced melanoma
- Regular transfusions reduced stroke recurrence in pediatric sickle cell anemia
- AR-V7 linked to treatment resistance in castration-resistant prostate cancer
- Aspirin reduced risk for recurrent VTE
-
- Cetuximab plus radiation, cisplatin yielded little benefit in advanced head and neck cancers
- Identification of 102 genes may help classify, treat patients with polycythemia vera
- Lenalidomide–dexamethasone extended PFS, OS in transplant-ineligible multiple myeloma
- Meta-analysis identifies predictors of chronic childhood immune thrombocytopenia
- Modified gene therapy shows promise in SCID-X1
- MRI could be key screening component for women at high risk for breast cancer
- Patients with primary invasive melanoma at increased risk for subsequent invasive melanoma
- PET/CT after one chemotherapy cycle highly prognostic in Hodgkin’s lymphoma
-
- Risk-adjusted model reveals little variation in hospital readmissions after colorectal cancer surgery
- Tumor-infiltrating lymphocytes predicted outcomes in triple-negative breast cancer
- Tumor stage after neoadjuvant chemotherapy predicted post-surgery survival in esophageal adenocarcinoma
- CTL019 therapy conferred 90% remission rate in relapsed, refractory ALL
- PALB2 mutation associated with increased risk for breast cancer
- AACI presents research award
- ASH elects four executive committee members
- Northwestern University cancer center appoints director
-
- Nurses’ association names president-elect
- UCLA researcher receives NIH award
- Vanderbilt professor receives research award
- Institute of Medicine elects 70 new members
- Medicare program improved breast cancer hormonal therapy adherence
- Oncology, palliative care partnership reduced patients’ lengths of stay, readmission rates
- Gender, lymph node ratio linked to papillary thyroid carcinoma recurrence
- Increased imaging improved early detection in well-differentiated thyroid cancer
-
- Many cancer survivors face financial, work-related hardships
- BRAF mutation linked to recurrence in differentiated thyroid cancer
- Hospice symptom management system benefited patients, caregivers
- Nomogram predicts prognosis, guides follow-up plans in patients with medullary thyroid cancer
- Painless thyroiditis syndrome associated with PD-1 treatment in patients with cancer
- Postoperative symptomatic hypocalcemia linked to preoperative vitamin D deficiency in thyroid cancer
- Patients often change lifestyle, medical care due to cancer costs
- Physician tumor board participation linked to clinical trial enrollment
-